ESSENTIAL HYPERLIPEMIA
Authors: S JOOB, P KARPATI
Journal: Annals of Internal Medicine (1958)

Case Reports1 December 1958ESSENTIAL HYPERLIPEMIAB. C. PAYNE, M.D., A. M. WALDRON, M.D., F.A.C.P.B. C. PAYNE, M.D.Search for more papers by this author, A. M. WALDRON, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-49-6-1420 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptEssential hyperlipemia is a disease of rather recent recognition. Described first by Holt et al. in 1939,11 it was repeatedly reported in pediatric literature as a relatively benign condition. Almost 10 years later, reports from Scandinavia and America indicated a high incidence of coronary heart disease at a relatively early age in adults. An excellent descriptive analysis of the condition was published by Joyner13 in 1953. More recent reports only emphasize the frequency of associated coronary atherosclerosis (10 of 17 case reports).15, 17The condition has definite familial tendencies, and no racial predilection can be anticipated on the basis...Bibliography1. AhrensKunkel EHHG: The stabilization of serum lipid emulsions by serum phospholipids, J. Exper. Med. 90: 409, 1949. CrossrefMedlineGoogle Scholar2. BloomfieldShenson AB: The syndrome of idiopathic hyperlipemia with crises of violent abdominal pain, Stanford M. Bull. 5: 185, 1947. MedlineGoogle Scholar3. BernsteinWilliamsHummelShepherdErickson SSHHFCMLBN: Metabolic observations on a child with essential hyperlipemia, J. Pediat. 14: 570, 1939. CrossrefGoogle Scholar4. ChapmanKinney FT: Hyperlipemia, Am. J. Dis. Child. 62: 1014, 1941. CrossrefGoogle Scholar5. FrankLevitt LL: Idiopathic hyperlipemia with secondary xanthomatosis, Arch. Dermat. and Syph. 64: 434, 1951. CrossrefGoogle Scholar6. Fulton JK: Essential hyperlipemia, acute gout, peripheral neuritis and myocardial disease in a Negro male, Arch. Int. Med. 89: 303 (Feb.) 1952. CrossrefGoogle Scholar7. GoodmanShumanGoodman MHS: Idiopathic hyperlipemia with secondary xanthomatosis, hepatosplenomegaly and lipemia retinalis, J. Pediat. 61: 596, 1940. CrossrefGoogle Scholar8. GrossmanHitz EEJB: Lipemia retinalis associated with essential hyperlipemia, Arch. Ophth. 40: 570, 1948. CrossrefGoogle Scholar9. Harslof E: Idiopathic familial hyperlipemia attended with hepatosplenomegaly, Acta med. Scandinav. 130: 140, 1948. CrossrefMedlineGoogle Scholar10. Hetzel PS: Idiopathic hyperlipemia with report of two cases, occurring in one family, M. J. Australia 2: 396 (Sept.) 1951. CrossrefMedlineGoogle Scholar11. HoltAylwardTimbres LEFXHG: Idiopathic familial lipemia, Bull. Johns Hopkins Hosp. 64: 279, 1939. Google Scholar12. Hopgood WC: Idiopathic hyperlipemia, New England J. Med. 238: 429, 1948. CrossrefMedlineGoogle Scholar13. Joyner CR: Essential hyperlipemia, Ann. Int. Med. 38: 759, 1953. LinkGoogle Scholar14. KoszalkaLevin MFJL: Idiopathic hyperlipemia, Ann. Int. Med. 33: 473, 1950. LinkGoogle Scholar15. LeverWaddell WW(a) : Idiopathic hyperlipemia and primary hypercholesteremic xanthomatosis. VII. Effects of intravenously administered fat on the serum lipids, J. Invest. Dermat. 25: 233 (Oct.) 1955. (b) Lever, W. F., Smith, P. A., and Hurley, N. A.: Idiopathic hyperlipemic and primary hypercholesteremic xanthomatosis. I. Clinical data and analysis of the plasma lipids, J. Invest. Dermat. 22: 33 (Jan.) 1954. (c) Lever, W. F., Smith, P. A., and Hurley, N. A.: Idiopathic hyperlipemia and primary hypercholesteremic xanthomatosis. III. Effects of intravenously administered heparin on the plasma proteins and lipids, J. Invest. Dermat. 22: 71, 1954. CrossrefMedlineGoogle Scholar16. Levy B: Idiopathic lipemia, J. Pediat. 29: 367, 1946. CrossrefMedlineGoogle Scholar17. MalmrosSwahnTruedsson HBE: Essential hyperlipaemia, Acta med. Scandinav. 149: 91, 1954. CrossrefMedlineGoogle Scholar18. MovittGerstlSherwoodEpstein ERBFCC: Essential hyperlipemia, Arch. Int. Med. 87: 79, 1951. CrossrefGoogle Scholar19. Thannhauser SJ(a) : Lipoidoses, 1950, Oxford University Press, New York. (b) Thannhauser, S. J., and Stanley, M.: Serum fat curves following oral administration of I131 labeled neutral fat to normal subjects and those with idiopathic hyperlipemia, Tr. A. Am. Physicians 62: 245, 1949. Google Scholar20. Wilkinson CF: Personal communication. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Ann Arbor, Michigan*Received for publication April 29, 1957.Requests for reprints should be addressed to B. C. Payne, M.D., St. Joseph Mercy Hospital, Ann Arbor, Michigan. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 December 1958Volume 49, Issue 6Page: 1420-1426KeywordsAtherosclerosisCoronary heart diseaseFatsHyperlipidemiaIngestionLactoseStable coronary artery disease Issue Published: 1 December 1958 PDF downloadLoading ...